Skip to content
  • About
    • Who We Are
    • Leadership
  • Services
    • Amplity Medical →
    • Amplity Commercial →
    • Amplity Intel →
    • Amplity MedComms →
    • Amplity Learn →
    • Amplity Recruiting →
  • Expertise
  • Our Work
  • Our News
  • Careers
  • About
    • Who We Are
    • Leadership
  • Services
    • Amplity Medical →
    • Amplity Commercial →
    • Amplity Intel →
    • Amplity MedComms →
    • Amplity Learn →
    • Amplity Recruiting →
  • Expertise
  • Our Work
  • Our News
  • Careers
Contact

Why Patients Switch Biologics In UC & CD

How GLP-1 RAs Usage Is Changing Obesity & Diabetes Care 

Urban-Rural Access to Bispecific Antibodies in Oncology

Research Explores The Ups & Downs Of GLP-1 Therapies

More PFI Patients Undergo Surgery Than Anticipated

Study Unlocks MG Subtypes + Severity From Notes

Study Finds Tolerable ASM For Refractory Epilepsy 

Study Finds Doctors Often Overlook Key RA Symptoms

Real-World Data Identifies GLP-1 RA Usage Patterns

Gaps In Lung Cancer Biomarker Testing & Therapy

← Previous
Next →
Amplity.svg
About
Who We Are
Leadership
Services
Amplity Medical
Amplity Commercial
Amplity Intel
Amplity MedComms
Amplity Learn
Amplity Recruiting
Expertise
Our Work
Our News
Articles
Events
Research
Careers
Contact
Amplity
2050 Cabot Blvd. West #110
Langhorne, PA 19047
© 2026 Amplity, Inc. All Rights Reserved.
Privacy & Cookie Statements
Terms of Use
Site Map